What is the appropriate acyclovir regimen for treating facial herpes, including dosing, route, duration, and adjustments for renal impairment or immunocompromised patients?

Acyclovir for Facial Herpes (Herpes Labialis)

Recommended Regimen

For immunocompetent adults with facial herpes (herpes labialis), treat with oral acyclovir 400 mg five times daily for 5 days, initiated at the earliest sign or symptom of recurrence. 1, 2

Treatment Approach

Acute Episode Treatment

• Standard dosing: Acyclovir 400 mg orally every 4 hours, 5 times daily for 5 days 1, 2
• Timing is critical: Treatment must begin within 1 hour of first prodromal symptoms (tingling, burning) or at the erythema stage for maximum benefit 2
• When initiated early, acyclovir reduces pain duration by 36% and healing time by 27% in patients who start during prodrome or erythema stages 2

Alternative Dosing Considerations

• Higher dose option: 400 mg three times daily for 3-5 days is also effective, though less frequently studied for herpes labialis 3
• Viral shedding is significantly reduced (25% vs 48% positive cultures with placebo) even when lesion development is not completely prevented 2

Renal Impairment Adjustments

Dose modifications are mandatory in renal dysfunction to prevent nephrotoxicity and CNS toxicity: 1

• Creatinine clearance >10 mL/min: 400 mg every 12 hours
• Creatinine clearance 0-10 mL/min: 200 mg every 12 hours
• Hemodialysis patients: Administer an additional dose after each dialysis session, as hemodialysis removes 60% of plasma acyclovir over 6 hours 1
• Peritoneal dialysis: No supplemental dosing needed beyond interval adjustment 1

Nephrotoxicity Prevention

• Maintain adequate hydration throughout treatment 1
• Exercise caution when combining with other nephrotoxic agents, as this increases risk of renal dysfunction and reversible CNS symptoms 1

Immunocompromised Patients

• Extended duration: Treat for longer than 5 days in immunocompromised hosts, though specific duration should be guided by clinical response 3
• Consider higher doses: 400 mg three times daily may be more appropriate 3
• Intravenous acyclovir is indicated for severe mucocutaneous herpes in immunocompromised patients 4, 5

Suppressive Therapy for Frequent Recurrences

For patients with frequent facial herpes outbreaks:

• Chronic suppression: 400 mg twice daily for extended periods (up to 12 months, then reassess) 1
• Alternative regimens range from 200 mg three times daily to 200 mg five times daily 1
• Sunscreen (SPF 15 or above) alone can effectively prevent UV-triggered recurrences 3
• Suppressive therapy does not eradicate latent virus; recurrences return to baseline frequency after discontinuation 5, 6

Key Clinical Pitfalls

• Delayed initiation: The most common error is starting treatment too late—efficacy drops dramatically if treatment begins after vesicle formation 2
• Inadequate dosing frequency: Five times daily dosing (every 4 hours while awake) is necessary for therapeutic levels; less frequent dosing reduces efficacy 1
• Forgetting renal adjustment: Failure to adjust for renal impairment can cause crystalluria, elevated creatinine, and CNS toxicity 1, 4
• Patient expectations: Counsel that acyclovir does not cure herpes or eliminate latent virus, and recurrences will continue after treatment stops 1, 5

Topical Alternatives

• 5% acyclovir cream may reduce lesion duration if applied very early, but systemic therapy is more effective 3
• Topical therapy has not proven clinically useful for recurrent labial herpes in most studies 6